Next Oncology-San Antonio

San Antonio, Texas 78240

12 studies enrolling now · 21 studies all time

What they study most

Advanced Cancer, Advanced Colorectal Carcinoma, Advanced Metastatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor, Advanced Solid Tumors, Advanced or Metastatic KRAS-mutant Tumor, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer, Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Appendiceal Adenocarcinoma, BRAF Gene Mutation

Studies at this site

• A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors — Recruiting now
• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
• Study of DCC-2812 in Participants With Advanced Genitourinary Cancers — Recruiting now
• First in Human Study of TUB-030 in Patients With Advanced Solid Tumors — Recruiting now
• A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies — Recruiting now
• A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors — Recruiting now
• Study of APR-1051 in Patients With Advanced Solid Tumors — Recruiting now
• Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors — Recruiting now
• A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies — Recruiting now
• Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. — Recruiting now
• A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors — Recruiting now
• A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 — Recruiting now
• Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors — Running, not enrolling
• Study Of ATRN-119 In Patients With Advanced Solid Tumors — Completed
• Study of IK-595 in RAS- or RAF-altered Advanced Tumors — Stopped early
• A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions — Stopped early
• A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 — Paused
• Safety and Tolerability of Intravenous Administration of ICVB-1042 — Stopped early
• Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer — Completed
• A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer — Completed
• Oral AMXT 1501 Dicaprate in Combination With DFMO — Completed